New Competitive Intelligence Report on Prophylactic and Therapeutic Vaccines against Cancer Published by

11 Nov 2011 • by Natalie Aster
New Competitive Intelligence Report on Prophylactic and Therapeutic Vaccines against Cancer Published by

LONDON – Two major areas of research aimed at developing better cancer treatment vaccines involve the identification of novel cancer-associated antigens that may prove more effective in stimulating immune responses than the already known antigens and the development of methods to enhance the ability of cancer-associated antigens to stimulate the immune system.

The most promising avenue of cancer vaccine research is aimed at better understanding the basic biology underlying how immune system cells and cancer cells interact. New technologies are being created as part of this effort. For example, a new type of imaging technology allows researchers to observe killer T cells and cancer cells interacting inside the body.

Researchers are also trying to identify the mechanisms by which cancer cells evade or suppress anticancer immune responses. A better understanding of how cancer cells manipulate the immune system could lead to the development of new drugs that block those processes and thereby improve the effectiveness of cancer treatment vaccines.

New research report “Competitor Analysis Cancer Vaccines” worked out by La Merie SL provides a competitor evaluation in the field of novel prophylactic and therapeutic vaccines against cancer. It includes a compilation of currently active projects in R&D for prophylaxis and therapy of cancer. In addition, the report lists company-specific R&D pipelines of cancer vaccines.

Competitor projects are listed in a tabular format according to their main antigenic constituents and provide information on:

  • drug codes;
  • target / mechanism of action;
  • class of compound;
  • company;
  • product category;
  • indication;
  • R&D stage;
  • additional comments with a hyperlink leading to the source of information. 

Report Details:

Title: Competitor Analysis Cancer Vaccines
Published: November, 2011
Pages: 151
Price: US$ 964

Competitor Analysis Reports on Vaccines and Active R&D Projects for Prophylaxis and Treatment of other Diseases are also Available:

More new competitive intelligence reports and other studies by the publisher can be found at La Merie SL page.


The Market Publishers, Ltd.
Mrs. Tanya Rezler
Tel: +44 208 123 2220
Fax: +44 207 900 3970